Browsing Tag
Baker McKenzie
3 posts
Chemomab Therapeutics (CMMB) and Scipher Medicine to merge in $150m reverse deal
Scipher Medicine and Chemomab are merging in all-stock deal, taking Scipher public via reverse merger. $30M PIPE led by Northpond. Q4 2026 close, H1 2028 Phase 2 data.
FORVIA agrees to sell Interiors unit to Apollo Funds for €1.8bn in IGNITE strategy push
FORVIA to sell Interiors to Apollo at 3.1x EBITDA. The €1.82bn deal cuts debt by €1bn but reveals how cheaply European suppliers must now sell scale.
Count Limited (ASX: CUP) to acquire Oracle Group for A$72.2m to accelerate wealth platform ambitions
Count Limited (ASX: CUP) acquires Oracle Group for A$72m to accelerate wealth platform ambitions. Read the full strategic and market analysis.